Evidence map›Paper›PMID 41331724›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2025

Can reporting mood swings during oral contraceptive use predict peripartum depression? Results from the Swedish longitudinal cohort study Mom2B.

Erietta Karaviti, Hanna Wierenga, Femke Geusens, Frida Gyllenberg, Fotios C Papadopoulos, Alkistis Skalkidou

Abstract read
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erietta KaravitiDepartment of Women's and Children's Health, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0009-0004-8554-6236
Hanna WierengaDepartment of Women's and Children's Health, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0009-0001-8550-4763
Femke GeusensDepartment of Women's and Children's Health, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0000-0002-3600-2249
Frida GyllenbergDepartment of Women's and Children's Health, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0000-0003-4740-5948
Fotios C PapadopoulosDepartment of Medical Sciences, Clinical Psychiatry, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0000-0002-8692-3652
Alkistis SkalkidouDepartment of Women's and Children's Health, https://ror.org/048a87296Uppsala University, Uppsala, Sweden.ORCID 0000-0002-4935-7532

Funding

Deutsche Forschungsgemeinschaft IRTG2804Finska LäkaresällskapetHjärt-Lungfonden FO2021-0161Hjärt-Lungfonden FO2022-0098Olle Engkvists Stiftelse 224-0064Vetenskapsrådet 2020-01965Vetenskapsrådet 2024-03199
6 · The paper itself

Abstract

backgroundPeripartum depression (PPD) is one of the most common pregnancy complications; nevertheless, it often goes underdiagnosed. Pinpointing important correlates is crucial for early risk identification and pathophysiology understanding. We aimed to investigate the association between self-reported mood swings during oral contraceptive (OC) use and peripartum depressive symptoms (PPDS).

methodsWe used data from the Swedish longitudinal cohort study Mom2B. 3829 women who had reported previous usage of OCs were included. Self-reported mood swings during OC use were assessed through a single question, and PPDS were evaluated using established cut-offs of the Edinburgh Postnatal Depression Scale (EPDS).

resultsSelf-reported mood swings during OC use were associated with PPDS at gestational weeks 12-22 (OR = 1.30, 95% CI, 1.01-1.66), 24-34 (OR = 1.37, 95% CI, 1.10-1.71) and 36-42 (OR = 1.39, 95% CI, 1.05-1.82) as well as at postpartum weeks 6-13 (OR = 1.46, 95% CI, 1.12-1.92) and 24-35 (OR = 2.07, 95% CI, 1.43-2.99). Interestingly, self-reported mood swings during OC use were associated with higher odds for newly developed PPDS in early postpartum (OR for weeks 6-13 = 1.92, 95% CI: 1.19-3.08).

conclusionsWomen with self-reported mood swings during OC use have higher risk of experiencing depressive symptoms across the peripartum period and twice the risk of newly developed PPDS during the early postpartum, adding to current evidence of a hormonal sensitive subgroup of women and the opportunity to use this simple question in future predictive efforts.

Indexed as

Contraceptives, OralDepressionDepression, PostpartumPeripartum PeriodAdultFemaleHumansLongitudinal StudiesPregnancySelf ReportSwedenYoung AdultContraceptives, Oraldepressionmood swingsoral contraceptives

Identifiers

PMID41331724
PMCPMC12816930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.